Central terminals of nociceptors are targets for nicotine suppression of inflammation.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 14706790)

Published in Neuroscience on January 01, 2004

Authors

F J P Miao1, P G Green, N Benowitz, J D Levine

Author Affiliations

1: NIH Pain Center UCSF, University of California at San Francisco, Schools of Medicine and Dentistry, 521 Parnassus Avenue, 94143-0440, San Francisco, CA, USA.

Articles by these authors

The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (1997) 30.59

The mechanism of placebo analgesia. Lancet (1978) 4.10

Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. Proc Natl Acad Sci U S A (1996) 2.84

A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice. Neuron (1999) 2.82

Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion. Clin Pharmacol Ther (2008) 2.49

Antinociceptive and motor effects of delta/mu and kappa/mu combinations of intrathecal opioid agonists. Pain (1992) 2.49

Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med (1996) 2.27

Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. J Neurosci (2000) 2.20

Mechanical transduction by rat dorsal root ganglion neurons in vitro. Neurosci Lett (1999) 2.11

Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide. J Clin Invest (1984) 1.94

Functional isolation and characterization of human hematopoietic stem cells. Science (1995) 1.92

Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol (1999) 1.92

Characterization of six voltage-gated K+ currents in adult rat sensory neurons. J Neurophysiol (1996) 1.91

Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med (1990) 1.89

Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med (1990) 1.89

Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro. J Neurosci (1998) 1.88

A new role for cryptochrome in a Drosophila circadian oscillator. Nature (2001) 1.85

Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci (1986) 1.84

Intraneuronal substance P contributes to the severity of experimental arthritis. Science (1984) 1.77

Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord. J Neurosci (1990) 1.77

The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Pharmacogenomics J (2004) 1.74

A tetrodotoxin-resistant sodium current mediates inflammatory pain in the rat. Neurosci Lett (1998) 1.67

The narcotic antagonist naloxone enhances clinical pain. Nature (1978) 1.66

Role of interleukin-6 in chronic muscle hyperalgesic priming. Neuroscience (2008) 1.65

Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature (1979) 1.63

Role of protein kinase A in the maintenance of inflammatory pain. J Neurosci (1999) 1.63

Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience (1989) 1.62

Leukotriene and prostaglandin sensitization of cutaneous high-threshold C- and A-delta mechanonociceptors in the hairy skin of rat hindlimbs. Neuroscience (1987) 1.62

Molecular analysis of mammalian timeless. Neuron (1998) 1.60

Effect of sympathetic activity on capsaicin-evoked pain, hyperalgesia, and vasodilatation. Neurology (1999) 1.59

Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report. Eur Heart J (2000) 1.59

Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy. Clin Pharmacol Ther (2010) 1.59

Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience (1991) 1.54

Co-expression of nociceptor properties in dorsal root ganglion neurons from the adult rat in vitro. Neuroscience (1996) 1.53

Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science (1984) 1.53

Nociceptor sensitization by extracellular signal-regulated kinases. J Neurosci (2001) 1.49

Predictors of cotinine levels in US children: data from the Third National Health and Nutrition Examination Survey. Chest (2001) 1.47

Pain-induced analgesia mediated by mesolimbic reward circuits. J Neurosci (1999) 1.44

Transient attenuation of protein kinase Cepsilon can terminate a chronic hyperalgesic state in the rat. Neuroscience (2003) 1.42

Hypothesis: the nervous system may contribute to the pathophysiology of rheumatoid arthritis. J Rheumatol (1985) 1.42

Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma. J Clin Oncol (1991) 1.41

Lidocaine toxicity in primary afferent neurons from the rat. J Pharmacol Exp Ther (1998) 1.41

Expression of c-fos protein in interneurons and projection neurons of the rat spinal cord in response to noxious somatic, articular, and visceral stimulation. J Comp Neurol (1989) 1.38

Benzene forms hydrogen bonds with water. Science (1992) 1.37

Chronic hyperalgesic priming in the rat involves a novel interaction between cAMP and PKCepsilon second messenger pathways. Pain (2005) 1.34

Smokeless tobacco use and health effects among baseball players. JAMA (1990) 1.33

The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain. Pain (1999) 1.33

Thrombin-mediated release of factor VIII antigen from human umbilical vein endothelial cells in culture. Blood (1982) 1.32

Hyperalgesic priming is restricted to isolectin B4-positive nociceptors. Neuroscience (2010) 1.30

Nitric oxide signaling in pain and nociceptor sensitization in the rat. J Neurosci (1998) 1.28

Role of protein kinase Cepsilon and protein kinase A in a model of paclitaxel-induced painful peripheral neuropathy in the rat. Neuroscience (2001) 1.28

Influence of the method of drug administration on analgesic response. Nature (1985) 1.27

Neural control of vascular permeability: interactions between primary afferents, mast cells, and sympathetic efferents. J Neurophysiol (1989) 1.26

Hyperthermia associated with drug intoxication. Crit Care Med (1986) 1.25

Clinical studies of cannabis tolerance and dependence. Ann N Y Acad Sci (1976) 1.25

Caffeinated beverages, decaffeinated coffee, and spontaneous abortion. Epidemiology (1997) 1.24

Key role for the epsilon isoform of protein kinase C in painful alcoholic neuropathy in the rat. J Neurosci (2000) 1.23

Neurophysiology of flight in wild-type and a mutant Drosophila. Proc Natl Acad Sci U S A (1973) 1.23

Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat. J Comp Neurol (2000) 1.23

Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma. Prog Brain Res (1996) 1.23

Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience (1992) 1.22

Autonomic components of the human pupillary light reflex. Invest Ophthalmol Vis Sci (1990) 1.22

Heat transduction in rat sensory neurons by calcium-dependent activation of a cation channel. Proc Natl Acad Sci U S A (1997) 1.22

The contribution of training to sensitivity in the nociceptive paw-withdrawal test. Brain Res (1989) 1.21

Gender difference in analgesic response to the kappa-opioid pentazocine. Neurosci Lett (1996) 1.21

Determination of lidocaine in blood and tissues. Anesthesiology (1973) 1.19

Nicotine gum and behavioral treatment in smoking cessation. J Consult Clin Psychol (1985) 1.19

The contribution of neurogenic inflammation in experimental arthritis. J Immunol (1985) 1.19

Causalgia and reflex sympathetic dystrophy: does the sympathetic nervous system contribute to the generation of pain? Muscle Nerve (1999) 1.18

Role of a Ca(2+)-dependent slow afterhyperpolarization in prostaglandin E2-induced sensitization of cultured rat sensory neurons. Neurosci Lett (1996) 1.17

Analgesic responses to morphine and placebo in individuals with postoperative pain. Pain (1981) 1.15

Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal. J Neurosci (1997) 1.15

Noradrenaline hyperalgesia is mediated through interaction with sympathetic postganglionic neurone terminals rather than activation of primary afferent nociceptors. Nature (1986) 1.14

Nociceptor subpopulations involved in hyperalgesic priming. Neuroscience (2009) 1.13

Clinical response to regional intravenous guanethidine in patients with rheumatoid arthritis. J Rheumatol (1986) 1.13

Peripheral nociceptive effects of alpha 2-adrenergic receptor agonists in the rat. Neuroscience (1995) 1.12

Direct cutaneous hyperalgesia induced by adenosine. Neuroscience (1990) 1.11

Changes in food intake and activity after quitting smoking. J Consult Clin Psychol (1989) 1.11

Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat. J Comp Neurol (1998) 1.11

What should be the elements of any settlement with the tobacco industry? Tob Control (1997) 1.11

Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens. Neuroscience (2001) 1.09

Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in the streptozotocin-diabetic rat. J Neurophysiol (1994) 1.09

Prostaglandins inhibit endogenous pain control mechanisms by blocking transmission at spinal noradrenergic synapses. J Neurosci (1988) 1.09

The foraging gene of Drosophila melanogaster: spatial-expression analysis and sucrose responsiveness. J Comp Neurol (2007) 1.09

Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players. Am J Public Health (1992) 1.08

Role of pain in placebo analgesia. Proc Natl Acad Sci U S A (1979) 1.08

Prostaglandins sensitize nociceptors in cell culture. Neurosci Lett (1991) 1.07

Formalin induces biphasic activity in C-fibers in the rat. Neurosci Lett (1996) 1.07

Reflex neurogenic inflammation. I. Contribution of the peripheral nervous system to spatially remote inflammatory responses that follow injury. J Neurosci (1985) 1.06

Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal. J Neurosci (1995) 1.04

The role of the polymorphonuclear leukocyte in hyperalgesia. J Neurosci (1985) 1.04

Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model. Clin Pharmacol Ther (1974) 1.03

Further substantiation of a significant role for the sympathetic nervous system in inflammation. Neuroscience (1993) 1.03

Activation of Gi induces mechanical hyperalgesia poststress or inflammation. Neuroscience (2009) 1.02

Caffeine consumption and menstrual function. Am J Epidemiol (1999) 1.02

Nociceptor hyper-responsiveness during vincristine-induced painful peripheral neuropathy in the rat. J Neurosci (1998) 1.01